Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF.
Bode D, Semmler L, Wakula P, Hegemann N, Primessnig U, Beindorff N, Powell D, Dahmen R, Ruetten H, Oeing C, Alogna A, Messroghli D, Pieske BM, Heinzel FR, Hohendanner F.
Bode D, et al.
Cardiovasc Diabetol. 2021 Jan 7;20(1):7. doi: 10.1186/s12933-020-01208-z.
Cardiovasc Diabetol. 2021.
PMID: 33413413
Free PMC article.